What is the global prevalence of frontotemporal lobe dementia with motor neuron disease (FTD/MND)?

1. Gibbons ZC, Richardson A, Neary D, Snowden JS. Behaviour in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008 Apr. 9(2):67-74. [Medline].

2. Woolley SC, Jonathan S Katz. Cognitive and behavioral impairment in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am. 2008 Aug. 19(3):607-17, xi. [Medline].

3. Lillo P, Savage S, Mioshi E, Kiernan MC, Hodges JR. Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum. Amyotroph Lateral Scler. 2012 Jan. 13(1):102-9. [Medline].

4. Giordana MT, Piccinini M, Grifoni S, De Marco G, Vercellino M, Magistrello M, et al. TDP-43 Redistribution Is an Early Event in Sporadic Amyotrophic Lateral Sclerosis. Brain Pathol. 2009 Mar 17. [Medline].

5. Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD. TDP-43 is intrinsically aggregation-prone and ALS-linked mutations accelerate aggregation and increase toxicity. J Biol Chem. 2009 May 22. [Medline]. [Full Text].

6. Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ. ALS and FTLD: two faces of TDP-43 proteinopathy. Eur J Neurol. 2008 Aug. 15(8):772-80. [Medline].

7. Mackenzie IR, Rademakers R. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Curr Opin Neurol. 2008 Dec. 21(6):693-700. [Medline].

8. Avants B, Khan A, McCluskey L, Elman L, Grossman M. Longitudinal cortical atrophy in amyotrophic lateral sclerosis with frontotemporal dementia. Arch Neurol. 2009 Jan. 66(1):138-9. [Medline].

9. Takeda T, Uchihara T, Arai N, Mizutani T, Iwata M. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease. Acta Neuropathol. 2009 Jan. 117(1):35-44. [Medline].

10. van der Graaff MM, de Jong JM, Baas F, de Visser M. Upper motor neuron and extra-motor neuron involvement in amyotrophic lateral sclerosis: a clinical and brain imaging review. Neuromuscul Disord. 2009 Jan. 19(1):53-8. [Medline].

11. Mackenzie IR, Neumann M. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis. Brain Res. 2011 Dec 13. [Medline].

12. Bäumer D, Talbot K, Turner MR. Advances in motor neurone disease. J R Soc Med. 2014 Jan. 107(1):14-21. [Medline].

13. Benatar M, Wuu J, Fernandez C, Weihl CC, Katzen H, Steele J, et al. Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology. 2013 May 14. 80(20):1874-80. [Medline]. [Full Text].

14. Hardy J, Rogaeva E. Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not. Exp Neurol. 2013 Nov 15. [Medline].

15. Wang X, Blanchard J, Grundke-Iqbal I, Wegiel J, Deng HX, Siddique T, et al. Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection. Acta Neuropathol. 2014 Feb. 127(2):243-56. [Medline].

16. Le NT, Chang L, Kovlyagina I, Georgiou P, Safren N, Braunstein KE, et al. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations. Proc Natl Acad Sci U S A. 2016 Nov 22. 113 (47):E7580-E7589. [Medline].

17. Turner MR. Motor neuron disease: biomarker development for an expanding cerebral syndrome. Clin Med (Lond). 2016 Dec. 16 (Suppl 6):s60-s65. [Medline].

18. Geevasinga N, Menon P, Özdinler PH, Kiernan MC, Vucic S. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol. 2016 Nov. 12 (11):651-661. [Medline].

19. Steele JC, McGeer PL. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology. 2008 May 20. 70(21):1984-90. [Medline].

20. Moon SY, Lee BH, Seo SW, Kang SJ, Na DL. Slow vertical saccades in the frontotemporal dementia with motor neuron disease. J Neurol. 2008 Sep. 255(9):1337-43. [Medline].

21. Rajagopalan V, Pioro EP. Distinct patterns of cortical atrophy in ALS patients with or without dementia: An MRI VBM study. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Feb 20. [Medline].

22. Jeong Y, Park KC, Cho SS, et al. Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease. Neurology. 2005 Feb 22. 64(4):734-6. [Medline].

23. Boyajian RA, Amo C, Otis SM, Romine JS, Smith RA. Magnetic source imaging of cortical dysfunction in amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2008 Jun. 87(6):427-37. [Medline].

24. Andersen PM. ALS and FTD: two sides of the same coin?. Lancet Neurol. 2013 Oct. 12(10):937-8. [Medline].

Jasvinder Chawla, MD, MBA Chief of Neurology, Hines Veterans Affairs Hospital; Professor of Neurology, Loyola University Medical Center

Jasvinder Chawla, MD, MBA is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Clinical Neurophysiology Society, American Medical Association

Disclosure: Nothing to disclose.

Jasvinder Chawla, MD, MBA Chief of Neurology, Hines Veterans Affairs Hospital; Professor of Neurology, Loyola University Medical Center

Jasvinder Chawla, MD, MBA is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Clinical Neurophysiology Society, American Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Reference Salary Employment

Joe Verghese, MD, MRCPI Associate Professor, Department of Neurology, Albert Einstein College of Medicine

Joe Verghese, MD, MRCPI is a member of the following medical societies: American Academy of Neurology and American Geriatrics Society

Disclosure: Nothing to disclose.